Dr Nicola Logan's current research interests include the development, progression and managment of myopia. Her work spans from basic laboratory experimentation and translate through to clinical trials that involve different strategies to slow myopia progression in children. Nicola runs both an active myopia research lab and a clinical service in myopia management. We run a number of clinical trials in myopia management and integrate findings into our clinical practice ensuring we offer the best evidence based options.
Areas of Expertise (4)
Development of Refractive Error
Aston University: MEd, Education 2017
Aston University: PhD, Optometry 1997
Aston University: BSc, Optometry 1992
Media Appearances (2)
Optometry Today online
Aston University senior lecturer, Dr Nicola Logan, outlined the importance of beginning myopia management early during her presentation, Evidence base for myopia management, at the College of Optometrists' annual conference, Optometry Tomorrow (18–19 March, Birmingham).
Children need more violet light – here’s why
The Conversation online
Short-sightedness is a global public health problem. Most people think of myopia (the medical term for short-sightedness) as an inconvenience because the blurred vision it causes is easily corrected with glasses or contact lenses. The problem is that a myopic eye is a longer eye and so the light sensitive part at the back of the eye is stretched. This can lead to a number of eye diseases in later life, such as glaucoma, maculopathy and retinal detachment.
Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)—study protocolBritish Journal of Ophthalmology
2020 To report the protocol of a trial designed to evaluate the efficacy, safety and mechanism of action of low-dose atropine (0.01%) eye-drops for reducing progression of myopia in UK children.
In vivo measures of anterior scleral resistance in humans with rebound tonometryOphthalmic and Physiological Optics
2020 To measure regional variations in anterior scleral resistance (ASR) using a ballistic rebound tonometer (RBT) and examine whether the variations are significantly affected by ethnicity and refractive error (RE).
Western Australia Atropine for the Treatment of Myopia (WA‐ATOM) study: Rationale, methodology and participant baseline characteristicsClinical & Experimental Ophthalmology
2020 Atropine eyedrops are a promising treatment for slowing myopia progression in East Asian children. However, its effects on children in Australia, including those of non‐Asian background, have not been well‐studied.
Global trends in myopia management attitudes and strategies in clinical practice – 2019 UpdateContact Lens and Anterior Eye
2020 A survey in 2015 identified a high level of eye care practitioner concern about myopia with a reported moderately high level of activity, but the vast majority still prescribed single vision interventions to young myopes. This research aimed to update these findings 4 years later.
Role of un‐correction, under‐correction and over‐correction of myopia as a strategy for slowing myopic progressionClinical and Experimental Optometry
2019 This systematic review investigates the association between un‐, under‐ and over‐correction of myopic refractive error and myopia progression in children and adolescents (up to 18 years of age). The literature search included three databases (PubMed, Web of Science, and Cochrane Central Register of Controlled Trials [CENTRAL]), and reference lists of retrieved studies in any language.